Establishing an immortalized human osteoprecursor cell line: OPC1

Area of Science:

• Cell Biology
• Biotechnology
• Orthopedics

Background:

• Establishing reliable human osteoprecursor cell lines is crucial for in vitro bone research.
• Existing models may lack consistency or the ability to undergo programmed differentiation.

Purpose of the Study:

• To evaluate the feasibility of creating a conditionally immortalized osteoprecursor cell line from human fetal bone.
• To characterize the osteogenic potential and differentiation capacity of the established cell line (OPC1).

Main Methods:

• Transfection of primary human fetal bone cells with a plasmid encoding SV40 T-antigen under an interferon-inducible promoter.
• Selection and characterization of neomycin-resistant clones for alkaline phosphatase (ALP) activity and osteogenic markers via RT-PCR.
• Induction of osteogenic differentiation using osteogenic supplements (OS) and recombinant human bone morphogenetic protein-2 (rhBMP-2).

Main Results:

• A clone, OPC1, exhibited high ALP activity and maintained osteogenic markers (OC, ON, OP, PTHr, ProI) from passage 10 to 30.
• OPC1 cells showed upregulated osteogenic gene expression in response to OS and formed mineralized nodules with rhBMP-2 treatment.
• OPC1 cells released intact osteocalcin (OC), confirming de novo synthesis and secretion under appropriate conditions.

Conclusions:

• The human-derived OPC1 cell line is a homogeneous and stable osteoprecursor model.
• OPC1 cells exhibit programmed differentiation capacity, responding to rhBMP-2.
• OPC1 provides a sensitive in vitro system for studying bone development, cell/biomaterial interactions, and screening bone differentiating factors.